Gates Foundation Grants $120M To PATH For Vaccine R&D, Deployment

GeekWire: PATH receives $120M Gates Foundation grant to fuel vaccine development across the globe
“Seattle-based global health nonprofit PATH announced Wednesday that it has received a $120 million grant from the Bill & Melinda Gates Foundation aimed at fueling the organization’s development and deployment of life-saving vaccines. The funds will go to the PATH Center for Vaccine Innovation and Access (CVIA), which launched last year with an initial $11 million in funding from the Gates Foundation. As part of the grant, CVIA also added four vaccine experts to its leadership team…” (McGrane, 9/6).

Seattle Times: Booster shot: Gates Foundation gives Seattle global health group $120 million for vaccine work
“…A $120 million grant to PATH’s Center for Vaccine Innovation and Access, announced Wednesday, will allow the program to operate more like a pharmaceutical company — focused not on profits but saving lives, said Dr. Trevor Mundel, Gates’ president of global health. … The four-year grant will boost PATH’s ability to work on a wide range of vaccines, including against pneumonia — now the leading infectious killer of children — and a range of respiratory and digestive infections, said PATH President and CEO Steve Davis…” (Doughton, 9/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.